Breast cancer.
Conditions
Interventions
At the start of the surgery and during anesthesia, the patient receives an intravenous injection with ICG compound in the cephalic vein. The lumpectomy procedure is followed in accordance with convent
Sponsors
University Medical Center Groningen (UMCG), Department of Surgery.
Eligibility
Inclusion criteria
Inclusion criteria: Women above the age of 18 who have biopsy-proven stage I-II breast cancer and who are planning to undergo lumpectomy as a treatment for their disease.
Exclusion criteria
Exclusion criteria: 1. Refusal of the patient to be included in the study; 2. Pregnant or breast-feeding; 3. Significant renal dysfunction (serum creatinine above 400 micromol/L); 4. Significant cardiac and/or pulmonary disease (ASA III-IV); 5. History of iodine allergy or anaphylactic reactions to insect bites or medication; 6. Presence or history of hyperthyroidism; 7. Recent surgery on the breast.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this pilot study is the feasibility of intra-operative detection of breast carcinoma with an ICG enhanced optical imaging device. | — |
Contacts
Public ContactG.M. Dam, van
University Medical Center Groningen Department of Surgery / BioOptical Imaging Center Groningen
Outcome results
None listed